Furthermore, Ling et al., 2022 reported a significant binding affinity of the bioactive compound celastrol towards nasopharyngeal carcinoma (NPC) targets, namely, IL6, VEGFA, and TNF. Here, IL6 is linked to nasopharyngeal carcinoma.